PolyPhotonix Limited and embecta UK have announced they have signed a co-promotional agreement under which embecta sales representatives will promote PolyPhotonix’s Noctura 400 Sleep Mask to healthcare professionals within the UK and Ireland.
PolyPhotonix is very proud that Noctura 400 has been featured on Look North, and about our increasing availability from NHS trusts.
Health Professionals get an opportunity to learn more about Noctura 400 and how it could benefit their patients and their clinics.
The Daily Mail reports how Noctura 400 could help 60,000 patients avoid eyeball injections and prevent diabetic sight loss while saving the NHS £240M a year.
It’s Diabetes Week – the Chief Investigator of a successful Noctura 400 study explains current state of the art treatments, including Noctura 400.
An Italian Noctura 400 patient talks about his diabetic experience and Noctura 400 treatment, on Pancreas 404, an Instagram initiative which aims to promote awareness of diabetes among young adults.
CEO Richard Kirk explains the technology behind Noctura 400 treatment for Diabetic Retinopathy and how optometrists could benefit from adding it to their portfolio.
